Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intraocular Lymphoma × Procarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 16 Hodgkin Disease 14 Central Nervous System Neoplasms 12 Astrocytoma 8 Oligodendroglioma 7 Brain Neoplasms 7 Gliosarcoma 5 Glioblastoma 5 Glioma 4 Neurotoxicity Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma, AIDS-Related 2 Recurrence 1 Radiation Injuries 1 Optic Nerve Glioma 1 Medulloblastoma 1 Intraocular Lymphoma 1 Familial ependymoma 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1 Ataxia Telangiectasia 1 Ataxia 1

Interventions

Cyclophosphamide 9 fludarabine phosphate 8 Whole-Body Irradiation 8 Rituximab 8 Cyclosporine 8 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 7 Mycophenolic Acid 6 Dexamethasone 5 Methotrexate 4 Etoposide 4 Vorinostat 3 Tacrolimus 3 Radiotherapy 3 Lenalidomide 3 Irinotecan 3 Cytarabine 3 Carboplatin 3 Busulfan 3 Bortezomib 3 laromustine 2 entinostat 2 Thiotepa 2 Therapeutics 2 Prednisone 2 Paclitaxel 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Flow Cytometry 2 Enzyme-Linked Immunosorbent Assay 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡